Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients
- 1 March 1991
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 83 (3) , 145-150
- https://doi.org/10.1111/j.1600-0404.1991.tb04666.x
Abstract
Altered prolactin and thyrotropin responses to the TRH test in parkinsonian patients are held to indicate an impairment of the tubero-infundibular dopaminergic axis (TIDA). We correlated the plasmatic prolactin (PRL), thyrotropin (TSH) and somatotropin (GH) responses to TRH and bromocriptine + TRH of 12 parkinsonian patients, who had never received anti-parkinsonian drugs, with the severity, the duration, the age of onset and the dopamine-dependence of the motor symptomatology as indicated by the therapeutic response to a six-month oral treatment with bromocriptine. Patients with basal motor impairment over 9 on the Webster Rating Scale (WRS), those with duration of the disease over 24 months and those with onset earlier than 55 years of age showed lower PRL responses than the respectively matched subgroups. Patients showing a therapeutic motor improvement over 50% on the WRS (dopamine-dependent or "responder") showed lower PRL and TSH and higher GH responses than the non-responders. These findings suggest that the TIDA impairment described in Parkinson's disease develops along with the progressive course of the extrapyramidal involvement and is strictly correlated with the dopamine-dependence of the motor impairment.Keywords
This publication has 24 references indexed in Scilit:
- Tuberoinfundibular Dopaminergic Function in Parkinson’s DiseaseEuropean Neurology, 1988
- Function of dopamine receptors in Parkinson's diseaseNeurology, 1986
- Thyrotrophin and prolactin responses to thyrotrophin-releasing hormone in patients with Parkinson's diseaseActa Endocrinologica, 1982
- Prolactin secretion in Parkinson diseaseNeurology, 1981
- Abnormal regulation of prolactin release in idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1980
- BROMOCRIPTINE INHIBITS PROLACTIN AND GROWTH-HORMONE RELEASE BY HUMAN PITUITARY TUMOURS IN CULTUREThe Lancet, 1977
- BROMOCRIPTINE IN PARKINSONISMThe Lancet, 1975
- Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-?-ErgocryptineJournal of Clinical Endocrinology & Metabolism, 1975
- INTRAVENOUS THYROTROPHIN-RELEASING HORMONE IN PARKINSON'S DISEASEThe Lancet, 1974
- EFFECT OF l-DOPA ADMINISTRATION ON GROWTH HORMONE SECRETION IN NORMAL SUBJECTS AND PARKINSONIAN PATIENTSJournal of Endocrinology, 1972